Genpharmasec Stock: price and insider trades · India
1 insider bought €111k of shares over the last 90 days, the latest by Rajesh Sadhwani, filed 01 Sept 2026.
Genpharmasec: what insiders have been doing
Genpharmasec is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). The last twelve months, up to 8 November 2026, brought 2 filings signed by 1 insider.
Not one open-market sale was filed. On the buying side, 1 insider reported 2 purchases totalling €111k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The largest single trade was a purchase of €65k by Rajesh Sadhwani, published on 1 September 2026, equal to 1.3% of the market capitalisation. Those buying include 1 senior executive.
The most recent open-market purchase was published on 1 September 2026, 68 days ago.
Across the 1,984 companies tracked on its exchange, the median is 4 filings; at 2 filings, this issuer sits below that mark. Looking back to 2026, when coverage begins, insiders filed 2 purchases and no sales.
This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -11.3%Entry ₹1.24 · Close at T+30 ₹1.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 6,500,000 shares@ ₹1.101.11% mcap58.7% of flowEquityMarket PurchaseSEBI:147e901aab0043cb580ac76785b338e84c2e2cdbCanonical exit: 30 Nov 2026 (T+90)
- 5,000,000 shares@ ₹1.000.78% mcap41.3% of flowEquityMarket PurchaseSEBI:87aeefdc6366c6b92c1d5de08ee6adb8de06db38Canonical exit: 29 Nov 2026 (T+90)
2 of 2 declarations
About Genpharmasec
Genpharmasec is a company specializing in the pharmaceutical sector, providing innovative solutions for drug safety. It is listed on the XBOM.